Qualigen Therapeutics Inc (QLGN) USD0.001

Sell:$3.17Buy:$3.31$0.10 (3.19%)

Prices delayed by at least 15 minutes
Sell:$3.17
Buy:$3.31
Change:$0.10 (3.19%)
Prices delayed by at least 15 minutes
Sell:$3.17
Buy:$3.31
Change:$0.10 (3.19%)
Prices delayed by at least 15 minutes

Company Information

About this company

Qualigen Therapeutics, Inc. is a clinical-stage therapeutics company. The Company is focused on developing treatments for adult and pediatric cancers. The Company’s business consists of one early-clinical-stage therapeutic program (QN-302) and one preclinical therapeutic program (Pan-RAS). Its lead program, QN-302, is an investigational small molecule G-quadruplexes (G4)-selective transcription inhibitor with strong binding affinity to G4s prevalent in cancer cells (such as pancreatic cancer). Its Pan-RAS program, which is at the preclinical stage, consists of a family of rat sarcoma virus (RAS) oncogene protein-protein interaction inhibitor small molecules inhibits or block mutated RAS genes’ proteins from binding to their effector proteins thereby leaving the proteins from the mutated RAS unable to cause further harm. Its QN-302 is in a Phase 1a clinical trial.

Key people

Campbell Becher
President, Director
Kevin Richardson
Interim Chief Executive Officer and Interim Chief Financial Officer, Director
Graydon Bensler
Independent Director
Braeden Lichti
Independent Director
Robert B. Lim
Independent Director
Cody Price
Independent Director
Click to see more

Key facts

  • EPIC
    QLGN
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • ISIN
    US74754R3012
  • Market cap
    $5.34m
  • Employees
    4
  • Shares in issue
    1.64m
  • Exchange
    NASDAQ
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.